Glucagon-like peptide-1 (GLP-1) receptor agonists show promise for treating fatty liver disease, particularly in patients with type 2 diabetes or obesity
Notably, another meta-analysis of 21 randomized controlled trials (RCTs) involving 25,957 patients with T2DM, obesity, or overweight demonstrated that semaglutide was linked to a lower risk of AF incidence (126)
These early results validate what weve believed from the start that employers dont have to choose between giving their people access to the most effective weight-loss treatments and managing costs responsibly
Treatment plans are designed around convenience and continuity, with guided intake, remote monitoring, and secure portal access supporting the overall patient experience
Although OA pathogenesis is exceedingly complex, recent studies underscore the multifactorial nature of the disease, involving mechanical overload, inflammatory responses, metabolic abnormalities, and cell death ( Cartilage deterioration and subchondral bone remodeling are hallmarks of OA